Serum phosphate levels and mortality risk among people with chronic kidney disease - PubMed (original) (raw)
Multicenter Study
doi: 10.1681/ASN.2004070602. Epub 2004 Dec 22.
Affiliations
- PMID: 15615819
- DOI: 10.1681/ASN.2004070602
Multicenter Study
Serum phosphate levels and mortality risk among people with chronic kidney disease
Bryan Kestenbaum et al. J Am Soc Nephrol. 2005 Feb.
Abstract
Elevated serum phosphate levels have been linked with vascular calcification and mortality among dialysis patients. The relationship between phosphate and mortality has not been explored among patients with chronic kidney disease (CKD). A retrospective cohort study was conducted from eight Veterans Affairs' Medical Centers located in the Pacific Northwest. CKD was defined by two continuously abnormal outpatient serum creatinine measurements at least 6 mo apart between 1999 and 2002. Patients who received chronic dialysis, those with a present or previous renal transplant, and those without a recent phosphate measurement were excluded. The primary end point was all-cause mortality. Secondary end points were acute myocardial infarction and the combined end point of myocardial infarction plus death. A total of 95,619 veterans with at least one primary care or internal medicine clinic contact from a Northwest VA facility and two or more outpatient measurements of serum creatinine, at least 6 mo apart, between January 1, 1999, and December 31, 2002, were identified. From this eligible population, 7021 patients met our definition of CKD. After exclusions, 6730 CKD patients were available for analysis, and 3490 had a serum phosphate measurement during the previous 18 mo. After adjustment, serum phosphate levels >3.5 mg/dl were associated with a significantly increased risk for death. Mortality risk increased linearly with each subsequent 0.5-mg/dl increase in serum phosphate levels. Elevated serum phosphate levels were independently associated with increased mortality risk among this population of patients with CKD.
Comment in
- Calcification or classification?
Chertow GM, Moe SM. Chertow GM, et al. J Am Soc Nephrol. 2005 Feb;16(2):293-5. doi: 10.1681/ASN.2004121115. Epub 2005 Jan 12. J Am Soc Nephrol. 2005. PMID: 15647332 No abstract available.
Similar articles
- The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
Phelan PJ, O'Kelly P, Walshe JJ, Conlon PJ. Phelan PJ, et al. Ren Fail. 2008;30(4):423-9. doi: 10.1080/08860220801964236. Ren Fail. 2008. PMID: 18569917 - Mortality risk stratification in chronic kidney disease: one size for all ages?
O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC. O'Hare AM, et al. J Am Soc Nephrol. 2006 Mar;17(3):846-53. doi: 10.1681/ASN.2005090986. Epub 2006 Feb 1. J Am Soc Nephrol. 2006. PMID: 16452492 - Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK. Goldfarb-Rumyantzev A, et al. Nephrol Dial Transplant. 2005 Jan;20(1):167-75. doi: 10.1093/ndt/gfh541. Epub 2004 Nov 16. Nephrol Dial Transplant. 2005. PMID: 15546892 - Epidemiology of chronic kidney disease in Italy: possible therapeutical approaches.
Locatelli F, Pozzoni P, Del Vecchio L. Locatelli F, et al. J Nephrol. 2003 Jan-Feb;16(1):1-10. J Nephrol. 2003. PMID: 12649529 Review.
Cited by
- Higher-order clinical risk factor interaction analysis for overall mortality in maintenance hemodialysis patients.
Yang CH, Moi SH, Chuang LY, Chen JB. Yang CH, et al. Ther Adv Chronic Dis. 2020 Sep 29;11:2040622320949060. doi: 10.1177/2040622320949060. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 33062235 Free PMC article. - Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
Houston J, Smith K, Isakova T, Sowden N, Wolf M, Gutiérrez OM. Houston J, et al. J Ren Nutr. 2013 Jan;23(1):12-20. doi: 10.1053/j.jrn.2011.12.009. Epub 2012 Mar 9. J Ren Nutr. 2013. PMID: 22406119 Free PMC article. - The Novel _gem_-Dihydroperoxide 12AC3O Suppresses High Phosphate-Induced Calcification via Antioxidant Effects in p53LMAco1 Smooth Muscle Cells.
Takase N, Inden M, Hirai S, Yamada Y, Kurita H, Takeda M, Yamaguchi E, Itoh A, Hozumi I. Takase N, et al. Int J Mol Sci. 2020 Jun 29;21(13):4628. doi: 10.3390/ijms21134628. Int J Mol Sci. 2020. PMID: 32610684 Free PMC article. - CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
Melamed ML, Buttar RS, Coco M. Melamed ML, et al. Adv Chronic Kidney Dis. 2016 Jul;23(4):262-9. doi: 10.1053/j.ackd.2016.03.008. Adv Chronic Kidney Dis. 2016. PMID: 27324680 Free PMC article. Review. - Nicotinamide and phosphate homeostasis in chronic kidney disease.
Ginsberg C, Ix JH. Ginsberg C, et al. Curr Opin Nephrol Hypertens. 2016 Jul;25(4):285-91. doi: 10.1097/MNH.0000000000000236. Curr Opin Nephrol Hypertens. 2016. PMID: 27219041 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous